State of Wisconsin Investment Board’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

State of Wisconsin Investment Board’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,700	Closed	-$304K	–	2240
2021 Q3	$304K	Sell	35,700 -11,000	-24%	-$155K	﹤0.01%	1940
2021 Q2	$766K	Sell	46,700 -3,100	-6%	-$62.6K	﹤0.01%	1539
2021 Q1	$1.1M	Buy	49,800 +2,900	+6%	+$79.1K	﹤0.01%	1341
2020 Q4	$1.45M	Buy	46,900 +3,400	+8%	+$86K	﹤0.01%	1252
2020 Q3	$884K	Buy	+43,500	New	+$764K	﹤0.01%	1318

Other funds holding TCRR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State of Wisconsin Investment Board's TCRR Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2021, closing a stake of 35,700 shares — an estimated $304K sold.

State of Wisconsin Investment Board first reported a position in TCRR in Q3 2020 and held it in 5 quarters. The position peaked at $1.45M in Q4 2020. 122 funds tracked by Wall St. Rank hold TCRR as of Q4 2021.

State of Wisconsin Investment Board reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 35,700 TCR2 Therapeutics Inc. Common Stock shares in Q4 2021, an estimated $304K.
State of Wisconsin Investment Board first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2020 and held it in 5 quarters.
State of Wisconsin Investment Board's TCR2 Therapeutics Inc. Common Stock position peaked at $1.45M in Q4 2020.
122 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.